Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Astera Labs (NASDAQ:ALAB) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 5 | 3 | 1 | 0 | 0 |
Last 30D | 4 | 3 | 1 | 0 | 0 |
1M Ago | 1 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $68.33, along with a high estimate of $80.00 and a low estimate of $55.00. This current average has decreased by 22.64% from the previous average price target of $88.33.
A clear picture of Astera Labs's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Harlan Sur | JP Morgan | Lowers | Overweight | $70.00 | $95.00 |
Ross Seymore | Deutsche Bank | Lowers | Buy | $60.00 | $85.00 |
Suji Desilva | Roth MKM | Lowers | Buy | $60.00 | $85.00 |
Tom O'Malley | Barclays | Lowers | Overweight | $70.00 | $85.00 |
Joseph Moore | Morgan Stanley | Lowers | Equal-Weight | $55.00 | $85.00 |
Richard Shannon | Craig-Hallum | Lowers | Buy | $75.00 | $90.00 |
Mark Lipacis | Evercore ISI Group | Lowers | Outperform | $80.00 | $98.00 |
Quinn Bolton | Needham | Lowers | Buy | $65.00 | $85.00 |
Tore Svanberg | Stifel | Lowers | Buy | $80.00 | $87.00 |
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Astera Labs's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Astera Labs analyst ratings.
Astera Labs Inc is a company that offers an Intelligent Connectivity Platform, comprised of Semiconductor-based, high-speed mixed-signal connectivity products that integrate a matrix of microcontrollers and sensors. COSMOS, their software suite which is embedded in its connectivity products and integrated into their customers' systems. The Company delivers critical connectivity performance, enables flexibility and customization, and supports observability and predictive analytics. This approach addresses the data, network, and memory bottlenecks, scalability, and other infrastructure requirements of hyperscalers and system original equipment manufacturers.
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Astera Labs's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 269.44% as of 31 March, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Astera Labs's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -142.5%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Astera Labs's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -26.16%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Astera Labs's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -17.53%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.0.
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ALAB